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Introduction
Glycosaminoglycans (GAGs) comprise chondroitin sulfate 
(CS), dermatan sulfate (DS), heparan sulfate (HS), keratan sulfate 
(KS), and hyaluronan. These GAGs are found in various tissues 
and are major components of the extracellular matrix (ECM). 
GAGs (except for hyaluronan) are sulfated polysaccharides made 
of repeating disaccharides, consisting of uronic acid (or galactose) 
and hexosamines. Polymeric GAGs are covalently bound through a 
linkage region to core proteins to yield proteoglycans (PGs), which 
have various biological functions. PGs play important roles in control 
of growth and differentiation. Particular sulfation patterns in the GAG 
chains allow interactions, normally of ionic nature, with growth factors. 
The PG protein cores are not just scaffolds for GAGs: they contain 
domains that have particular biological activities [1]. Many PGs are 
thus multifunctional molecules that engage in several different specific 
interactions simultaneously.
Mucopolysaccharidoses (MPS) are a group of lysosomal storage 
diseases caused by deficiency of the lysosomal enzymes required 
for degradation of GAGs. There are 11 known enzyme deficiencies, 
resulting in seven distinct forms of MPS with a collective incidence 
of approximately 1 in 25,000 live births. GAG accumulation causes a 
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Abstract
Glycosaminoglycans (GAGs) are distributed in the whole body and play a variety of important physiological roles 
associated with inflammation, growth, coagulation, fibrinolysis, lipolysis, and cell-matrix biology. Accumulation of 
undegraded GAGs in lysosomes gives rise to a distinct clinical syndrome, mucopolysaccharidoses. Measurement of 
each specific GAG in a variety of specimens is urgently required to understand GAG interaction with other molecules, 
physiological status of patients, and prognosis and pathogenesis of the disease.
We established a highly sensitive and accurate tandem mass spectrometry (LC-MS/MS) method for 
measurements of disaccharides derived from four specific GAGs [dermatan sulfate (DS), heparan sulfate (HS), 
keratan sulfate (KS), and chondroitin sulfate (CS)]. Disaccharides were produced by specific enzyme digestion of 
each GAG, and quantified by negative ion mode of multiple reaction monitoring. Subclasses of HS and GAGs with 
identical molecular weights can be separated using a Hypercarbcolumn (2.0 mm×50 mm, 5 µm) with an aectonitrile 
gradient in ammonium acetate (pH 11.0). 
We also developed a GAG assay by RapidFire with tandem mass spectrometry (RF-MS/MS). The RF system 
consists of an integrated solid phase extraction robot that binds and de-salts samples from assay plates and directly 
injects them into a MS/MS detector, reducing sample processing time to ten seconds. RF-MS/MS consequently 
yields much faster throughput than conventional LC-MS/MS-based methods. 
However, the RF system does not have a chromatographic step, and therefore, cannot distinguish GAGs that 
have identical molecular weights. Both methods can be applied to analysis of dried blood spots, blood, and urine 
specimens.
In this article, we compare the assay methods for GAGs and describe their potential applications.
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progressive damage of multiple tissues including brain, lung, heart, 
liver, kidney, joint, and bone. Most clinical signs and symptoms for 
MPS patients do not appear immediately after birth but onset of clinical 
signs and symptoms progresses with age. Although the symptoms and 
severity of MPS vary with each individual patient and its subtype of 
MPS, the average life span in most patients is one to two decades if 
untreated.
Currently, enzyme replacement therapy (ERT), hematopoietic stem 
cell transplantation, substrate reduction therapy and gene therapy are 
in clinical use or being investigated in clinical trials for patients with 
some types of MPS. Starting these treatments at birth or at very early 
stages has the greatest positive impact on the clinical course of the 
disease [2]. To provide a better efficacy and quality of life of the patients, 
early diagnosis and early treatment as well as accurate prognosis and 
monitoring are essential.
Newborn Screening (NBS) is recognized as an essential, preventive 
public health program for early identification of diseases in newborn 
that can affect their long-term health. Tandem mass spectrometry 
(MS/MS) has evolved as a powerful tool to detect small compounds 
because detection is based on the mass of the parent compound and 
a specific fragment(s) of the compound. Other sensitive detection 
methods, such as amperometric electrochemical detection, do not 
detect specific compounds and consequently quantitation will be 
compromised if other compounds co-elute with target compound 
after chromatographic separation. This is a particular concern in our 
studies of multiple disaccharides that have similar chromatographic 
and molecular properties. We developed a method that can assay DS, 
HS, and KS simultaneously in blood and/or urine samples using high 
performance liquid chromatography tandem mass spectrometry (LC-
MS/MS) for MPS [3-10]. The LC-MS/MS method could not only show 
sensitivity and specificity for detecting all subtypes of MPS but is also 
able to monitor therapeutic efficacy in MPS patients and animal models 
[2,6,10-12]. We show here that CS can be also measured simultaneously 
using a modification of this technique. 
The main drawback of the LC step is that the process is time 
consuming, limiting its utility for the screening of large numbers of 
NBS samples. The use of the RapidFire (RF) high-throughput mass 
spectrometry system removes the bottleneck of throughput, while 
maintaining the quality and reliability of standard MS/MS read-outs. 
Samples are absorbed to a matrix to concentrate and desalt, and then 
eluted directly into the MS/MS without chromatographic separation. 
Each sample is processed in less than ten seconds, yielding much faster 
throughput than conventional LC-MS/MS based methods. A single 
384 well plate can be read in ~45 min, indicating that this RF-MS/
MS system can analyze over one million samples annually. Moreover, 
the RF-MS/MS has been shown to provide sensitivity and specificity 
equivalent to a scintillation proximity assay [13], and LC-MS/MS 
system in some applications. [14]. The speed and efficiency of the RF 
can allow for experiments that would otherwise be deemed “untenable” 
under normal circumstances. The RF system has been validated as 
suitable for many drug discoveries [13,15-21], and ADME (Absorption, 
Distribution, Metabolism and Excretion) based applications [14]. 
Overall, establishment of GAG assays by tandem mass spectrometry 
are urgently required to apply to not only clinical indications but basic 
research. In this article, we describe GAGs assay methods by using LC-
MS/MS and RF-MS/MS, indicating their application in clinical and 
basic research.
Procedures of Tandem Mass Spectrometry for Assay of 
GAGs
Standards and enzymes
To digest “polymer” CS, DS, HS, and KS to disaccharides, the 
enzymes of chondroitinase C, chondroitinase B, heparitinase, and 
keratanase II, respectively, were provided from Sigma-Aldrich (St. Louis, 
MO) and Seikagaku Co. (Tokyo, Japan). Chondrosine (Seikagaku Co.) 
was used as an internal standard (IS), while unsaturated disaccharides, 
[ΔDiHS-0S, 2-acetamido-2-deoxy-4-O-(4-deoxy-a-L-threo-hex-
4-enopyranosyluronic acid)-D-glucose; ΔDiHS-NS, 2-deoxy-2-
sulfamino-4-O-(4-deoxy-a-L-threo-hex-4-enopyranosyluronic 
acid)-D-glucose; ΔDi-4S/6S (DS or CS), 2-acetamido-2-deoxy-4-O-
(4-deoxy-a-L-threo-hex-4-enopyranosyluronic acid)-4 or 6-O-sulfo-
D-glucose] were used for making standard curves. Stock solutions 
of ΔDi-6S (250 µg/ml), ΔDi-4S (250 µg/ml), ΔDiHS-0S (100 µg/ml), 
ΔDiHS-NS (100 µg/ml), ΔDiHS-6S (100 µg/ml), and IS (5 mg/ml) 
were prepared separately in ddH2O. Mono-sulfated KS [KS1; Galβ1-
4GlcNAc(6S)] and di-sulfated KS [KS2; Gal(6S)β1-4GlcNAc(6S)] were 
made by digestion of bovine cornea KS with keratanase II, since these 
disaccharides were not available. Sixty percent of KS-I was digested 
with keratanase II and that the ratio of Gal(6S)β1-4GlcNAc(6S) (KS1) 
toGalβ1-4GlcNAc(6S)(KS2) was 42:58 [22]. A stock solution of digested 
KS (1000 µg/ml KS1+KS2) in ddH2O was prepared.
For standard curves, dilutions of the stock solutions were prepared 
as follows: ΔDi-6S, ΔDi-4S, ΔDiHS-0S, ΔDiHS-NS, and ΔDiHS-6S (1, 
5, 10, 50, 100, 500, and 1000 ng/ml), and digested KS (0.01, 0.05, 0.1, 
0.5, 1, 5, and 10 µg/ml), each containing IS solution (50 ng/ml). 
ΔDi-4S is composed of DS, and ΔDi-C6S derived from CS, while 
ΔDiHS-0S, ΔDiHS-NS, and ΔDiHS-6S are subclasses of HS.KS 
comprises KS1 and KS2 (Figure 1). Note that ΔDi-4S, ΔDiHS-6S, and 
ΔDi-C6S have identical molecular weights.
Sample preparation
Purified polymer CS (shark cartilage), DS (pig skin), HS (bovine 
kidney), and KS (bovine cornea) were digested by a mixture of 
chondroitinase C (Sigma-Aldrich Co, St. Louis MO), chondroitinase B, 
heparitinase, and keratanase II (all other reagents except chondroitinase 
C provided by Seikagaku Co). Samples to be measured were centrifuged 
to remove insoluble material. Ten µL of the supernatant was mixed 
with 90 µL of 50 mM Tris-HCl Buffer (pH 7.0), and then added to a 
filter well. This was centrifuged at 2,500 g for 15 min to deplete low 
molecular compounds that could interfere with the assay. The filters 
were transferred to fresh plates and 20 µL of internal standard (500 
ng/mL chondrosine), 20 µL of 50 mM Tris-HCl buffer and 10 µL of 
chondroitinase C, chondroitinase B, heparitinase, and keratanase II, 
respectively, (each 2 mU/10 µL of 50 mM Tris-HCl buffer) were added 
onto each filter. Samples were incubated with shaking at 37°C for 15 hr 
to digest the GAGs. Filter plates were then centrifuged at 14,000 g for 
15 min. Twenty µL of ddH2O was added to each flow-through sample, 
and mixed by vortexing for 10 sec. Samples were stored at -20°C until 
injection to LC-MS/MS or RF-MS/MS. In a preliminary study we tested 
three different filter systems for efficiency of extraction and recovery: 
AcroPrepTM Advance 96-Well Filter Plates, with Ultra filtration Omega 
10K(PALL Co., NY, USA); Neonatal Screening, AcroPreptTM Advance 
96-Well Filter Plates (PALL Co.); and Amicon Ultra 10K device 
(Milipore Co.) and monitored recovery of Di4S and KS (Figure 2). The 
optimized Di-4S assay also detects Di-6S because these disaccharides 
have the same molecular mass and yield similar fragments. The KS 
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assay detects both mono and disulfated KS because the fragmentor 
can remove a sulfate from the disulfated form before it enters the mass 
spectrometer. The filter with the ultrafiltration Omega 10K filters gave 
the highest yield of disaccharides, especially for Di-4S.
Equipment
Liquid chromatography tandem mass spectrometry (LC-MS/
MS): The instrument used for high performance liquid chromatography 
tandem mass spectrometry (LC-MS/MS) was a 1260 infinity LC 
/6460 Triple Quad (Agilent Technologies, Palo Alto, CA, USA). 
Samples were removed from the -20°C and were allowed to thaw at 
an ambient temperature. Sample tubes were quickly spun by using a 
VWR Galaxy Ministar centrifuge to collect all samples to the bottom 
of the tube. Twenty-five µL of each sample was transferred to a 96 well 
polypropylene plate, and diluted with 25 µL of 50 mMTris buffer (pH 
7.5). The plate was centrifuged at 3,500 g for 5 min prior to analysis with 












MW ; 459.4ΔDi-6S: R1=H, R2=SO3H
CS
Chondroitinase C
Figure 1: Disaccharides after digestion of GAGs by enzymes. KS: Keratan sulfate; HS: heparan sulfate; DS:dermatan sulfate; 
CS: chondroitin sulfate.
 







































































Counts vs. Acquisition Time (min)









KS1   KS2Di-4S  Di-6S
Figure 2: Comparison of disaccharide elution between filters. The peak corresponding to Di-4S (DS) in the chromatogram after use of the Ultra filtration Omega 
10K filter was much larger than seen for the other filters. The amount of KS1 (mono-sulfated KS) and KS2 (di-sulfated KS) (right panel) was also higher from this 
filter than the neonatal screening filter (note scale of y-axis). Elution of HS was similar for all 3 filters (data not shown).*AcroPrep™ Advance 96-Well Filter Plates.
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analyzed using the RapidFire high-throughput mass spectrometry 
platform (Agilent Technologies, Inc: Santa Clara, CA). Individual AUC 
RapidFire tandem mass spectrometry (RF-MS/MS): The samples 
purified by the filters as described above for LC-MS/MS were also 
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Figure 4: Chromatograms in different pHs for Hypercarb. The samples were analyzed by using Hypercarb (2.0 mm×50 mm, 5 µm; Thermo Electron Corp.) with 
an acetonitrile gradient of 0% to 100% in 5 mM ammonium acetate. The range of pH tested was between pH 9.5 and pH 11.0. The chromatograms indicate that pH 
11.0 provides the highest peaks for ΔDiHS-NS, ΔDiHS-6S, and ΔDi-4S (DS).
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(areas under the curve) for each analyte in each sample was determined 
using the RapidFire Integrator software. Each sample was prepared and 
analyzed in duplicate on separate days. All GAG levels were measured 
and averaged.
LC-MS/MS: Determination of levels of disaccharides derived 
from GAGs
Chromatography and selectivity: Disaccharides were separated 
on a Hypercarb (2.0 mm×50 mm, 5 µm; Thermo Electron Corp.) 
column and eluted with an acetonitrile gradient of 0% to 100% in 5 mM 
ammonium acetate. Signals for ΔDiHS-6S, ΔDi-4S (DS), and ΔDi-6S 
(C6S) were very low at pH values below 11 (Figure 4), probably due 
to poor ionization of the sugars.Using purified preparations ofΔDiHS-
0S, ΔDiHS-NS, ΔDiHS-6S, ΔDi-4S, and ΔDi-6S, we optimized MRMs 
for each individual sugar and obtained single peaks corresponding to 
the pure compound (Figure 5). All disaccharides are eluted in less than 
3 min (Figure 5). As discussed earlier, although ΔDiHS-6S, ΔDi-4S 
(DS), and ΔDi-6S (C6S) have the same molecular weights, they elute at 
different times from the column, so they can be quantiifed separately.
Furthermore, the elution position of Di-4S varies dependent upon the 
sample preparation, and elutes at 0.9 min after extraction from some 
samples (e.g. Figure 4). All other disaccharides consistently eluted as 
seen for the standards.As discussed earlier, the detection method for 
mono-sulfated Galβ1-4GlcNAc(6S) (KS1) also detected some Gal(6S)
β1-4GlcNAc(6S) (KS2), due to loss of a sulfate, but the two forms were 
clearly separated by chromatography.
Calibration curves: Calibration parameters of disaccharides 
derived from CS, DS, HS, and KS were assessed. Calibration curves for 
Galβ1-4GlcNAc(6S) (KS1), Gal(6S)β1-4GlcNAc(6S) (KS2), ΔDiHS-0S 
(H0S), ΔDiHS-NS (HNS), and ΔDiHS-6S (H6S), ΔDi-6S (C6S), and 
ΔDi-4S (DS) are linear over the concentration ranges of 0.1to 10 µg/ml, 
0.1 to 10 µg/ml, 10 to 1,000 ng/ml, 10 to 1,000 ng/ml, 10 to 1,000 ng/ml, 
10 to 1,000 ng/ml, and 10 to 1,000 ng/ml, respectively. The correlation 
coefficients of determination (r) were not less than 0.98 (Figure 6).
Precision: The results of intra- and inter-assay precision for ΔDiHS-
0S, ΔDiHS-NS, and ΔDiHS-6S, ΔDi-6S, and ΔDi-4S in control serum 
are as follows. The intra-assay precision values/coefficient of variation 
(CV) determined from analysis of ΔDiHS-0S, ΔDiHS-NS, ΔDiHS-6S, 
ΔDi-6S, and ΔDi-4S for control serum are less than 8.9, 1.7, 11.7, 11.9, 
and 12.1%, respectively. The inter-assay precision values/CVs for these 
disaccharides in control serum are less than 7.0, 0.6, 12.2, 12.2, and 
12.4%, respectively. The intra-assay precision values/CVs for Galβ1-
4GlcNAc(6S) and Gal(6S)β1-4GlcNAc(6S) in control serum were less 
than 6.8 and 14.6% andinter-assay precision values/CVs were less than 
6.5 and 14.3% (Table 1). These results demonstrate the reproducibility 
and accuracy of the method.
RF-MS/MS: Disaccharide determination derived from GAGs
Chromatography: The RF system does not have a chromatographic 
separation step but rather samples are first bound to solid phase matrix 
for desalting and concentration and then eluted directly into an MS/
MS system. Consequently, ΔDiHS-6S, ΔDi-4S, and ΔDi-6S cannot 
be distingished because they have identical molecular weights and 
give similar mrms. However the MS/MS can distinguish and quantify 
combinations of different disaccharides (for example see chondrosine 
and ΔDiHS-NS in Figure 7). 
Calibration curves: Calibration parameters of disaccharides 
derived from DS, HS, and KS were assessed. Calibration curves for KS, 
ΔDiHS-0S, ΔDiHS-NS, and ΔDi-4S/6S are linear over the concentration 
ranges of 0.156 to 10.0 µg/ml, 16 to 1,000 ng/ml, 16 to 1,000 ng/ml, 
and 16 to 1,000 ng/ml, respectively. The correlation coefficients of 
determination (r) are 0.98 or more (Figure 8).
Precision: The results of intra- and inter-assay precision for 
ΔDiHS-0S, ΔDiHS-NS, and ΔDi-4S/6S in control serum are as follows. 
The disaccharide (ΔDi-4S) is detected by the same ions (m/z 462/97) 
as those of ΔDiHS-6S. Thus, the total concentration of disaccharides 
expressed as ΔDi-4S includes both ΔDi-4S and ΔDiHS-6S. The intra-
assay precision values/coefficient of variation (CV) determined from 
analysis of ΔDiHS-0S, ΔDiHS-NS, and ΔDi-4S for control serum are 
less than 6.7, 7.9, and 15.8%, respectively. The inter-assay precision 
values/CVs for these disaccharides in control serum are less than 
5.2, 6.8, and 14.8%, respectively (Table 2). The intra-assay precision 
values/CVs for Galβ1-4GlcNAc(6S) and Gal(6S)β1-4GlcNAc(6S) in 
control serum were less than 8.2 and 5.3% andinter-assay precision 
values/CVs were less than 6.6 and 5.7%. These results demonstrate the 
reproducibility and accuracy of the method.
Correlation of GAG levels between LC-MS/MS and RF-MS/
MS: We analyzed 59 different plasma samples for DiHS-NS, DiHS-0S, 
Di-4S, and KS by both LC-MS/MS and RF-MS/MS. The correlation 
between LC-MS/MS and RF-MS/MS determinations was tested by a 
simple linear regression analysis. We interpreted correlation strength 
as outlined by Johnston [23]. Briefly, correlations are interpreted based 
on r values as follows: 0.0 to 0.2, very weak to negligible correlation; 
0.2 to 0.4, weak correlation; 0.4 to 0.7, moderate correlation; 0.7 to 0.9, 
strong correlation. Data points that were greater than three standard 
deviations from the mean for each assay were considered outliers. 
Analysis was performed using SPSS for Windows (version 17.0, SPSS 
Inc., Chicago, IL, USA). The moderate correlation in serum ΔDiHS-NS 
and ΔDiHS-0S measurements of control subjects between LC-MS/MS 
and RF-MS/MS indicates that results from each assay are comparable 
(Figure 9). Measurements of KS also showed moderate correlation 
(data not shown).
Applications of GAG assays
Disaccharide GAGs assayed by LC-MS/MS have been used for 












CV=coefficient of variation 
Table 1: Intra- and inter-day precision of the method for determination of 
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Table 2: Intra- and inter-day precision of the method for determination of 
disaccharides in human control serum (RF-MS/MS).
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Figure 5: Chromatograms of disaccharides. Chromatograms for disaccharides of KS 1 and 2 (digested bovine cornea), ΔDiHS-NS, ΔDiHS-0S, ΔDiHS-6S, ΔDi-
4S (DS), ΔDi-6S (C6S), and chondrosine (IS). Polymer KS was separated with mono-sulfated KS [KS1: Galβ1-4GlcNAc(6S)] and di-sulfated KS [KS2: Gal(6S)β1-
4GlcNAc(6S)] after digestion by keratanase II. Equipment: 6460 Triple Quad MS/MS with 1260 infinity LC (Agilent Technologies). IS: Internal Standard.
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therapeutic efficacy in human patients and animal models with MPS 
[2,9-12,22,24-27]. In Figure 10, peaks corresponding to expected 
elution of each disaccharide are marked with arrows. MRM Parameters 
designed to detect Di-6S and DiHS-6S also detect Di-4S whereas the 
parameters specifically designed to detect Di-4S do not detect the low 
levels of Di-6S and DiHS-6S in these samples.A clear difference in Di-
4S level between a rat with MPS VI and a control rat was observed 
(Figure 11). 
Discussion
Our studies have demonstrated that an RF-MS/MS platform is 
capable of detecting disaccharides of ΔDiHS-0S, ΔDiHS-NS, ΔDi-4S/6S, 
and KS with similar reproducibility, sensitivity, and specificity as LC-
MS/MS [3-10], suggesting that the LC component may not be essential 
for detection and identification of these disaccharides. The strong 
correlation between the two methods for detection of disaccharides 
extracted from plasma indicates that non-specific interactions or signal 
quenching are not major concerns for the RF system for this application.
The filter system used in this study to remove low molecular weight 
components of serum and then to separate digested disaccharides from 
larger molecules appears to eliminate the need for further purification 
prior to MS/MS analysis. RF-MS/MS provides 25-100 fold faster 
throughput compared to conventional LC-MS/MS, and consequently 
may be more suitable for mass screening applications such as NBS.
RF-MS/MS may not be useful for all applications or tissue samples.
As there is no separation step, interfering compounds will not be 
distinguishable from the compound under study. We found that 
extracts of rat urine contained a number of interfering peaks, including 
one that had the same MRM as the internal standard (Figure 10). The 
significance of these false signals to this limited study require further 
clarification, but the data emphasize the need to ensure that samples 
will not give excessive levels or numbers of false positive signals prior 
to establishment of a RF technique. 
RF-MS/MS cannot distinguish ΔDi-4S, ΔDi-6S, and ΔDiHS-6S 
that have the same molecular weight, so LC-MS/MS will be required if 
quantities of specific disaccharides are required. 
GAG(s) play an important physiological role as PG and are 







































































Figure 6: Calibration curves for each disaccharide by LC-MS/MS. X-axis shows actual concentration of disaccharide, while Y-axis shows calculated concentration.
A) Galβ1-4GlcNAc(6S); KS1, Gal(6S)β1-4GlcNAc(6S); KS2, B) ΔDiHS-0S, ΔDiHS-NS, and ΔDiHS-6S, C) ΔDi-6S; C6S and ΔDi-4S; DS.
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Figure 7: Chromatograms of RF-MS/MS. a) Multiple injections of chondosine (Q1; 353.7, Q3; 192.5) with the same concentration shows 8 peaks per min. b) Multiple 
injections of ΔDiHS-NS (Q1; 416.0, Q3; 137.7) with a series of dilutions in duplicate shows seven gradient peaks per a set of dilutions (as well as other surrounding 
samples).
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Figure 8: Calibration curves for each disaccharide by RF-MS/MS. X-axis shows actual concentration of disaccharide in solution (ng/ml), while Y-axis shows measured 
AUC (arbitrary units).  KS comprises KS1 and KS2, and ΔDi-4S/6S comprises DS and DiHS-6S.
[28-31], ligament injury or trauma in the knee [32,33], spinal cord 
injury [34-36], and diabetes mellitus (DM) [37-39]. GAG assay by 
tandem mass spectrometry should be applied to diagnosis, prognosis, 
and therapeutic efficacy of these diseases. The LC-MS/MS method is 
also needed to investigate sulfation levels of HS and KS that can result 
in functional alterations of proteoglycans. RF-MS/MS will be more 
valuable for situations where rapid throughput is necessary such as in 
newborn screening.
GAGs are long, unbranched polysaccharides, and have a high 
negative charge because of acidic sugar residues and/or modifications 
by sulfate groups. The acidic sugar alternates with an amino sugar 
in repeated disaccharide units. The GAGs adopt an extended 
conformation, attract cations, and bind water. Hydrated GAG gels 
enable joints and tissues to absorb large pressure changes. 
After synthesis, PGs are transported from the Golgi to their 
destinations; ECM, the cell surface or intracellular organelles. Such 
determinant transport requires mechanisms for recognition, sorting 
and delivery. These mechanisms are critical in cells such as epithelial 
cells and neurons, where the cell membrane comprises separate 
domains. Recognition and sorting require determinant factors in the 
GAG chains and/or in the PG protein cores. Thus, the physiological 
role of GAGs is dependent upon tissue and/or cell type. Sulfation level 
of GAG(s) also varies with age, tissue, and pathological status. For 
instance, KS is almost always sulfated on C (6) of GlcNAc, while C (6) 
of Gal is sulfated to a variable extent, depending on the tissue and age 
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Figure 9: Correlation in GAG concentration between LC-MS/MS and RF-MS/MS.
A. ΔDiHS-NS concentration. Correlation in blood (plasma or serum) ΔDiHS-NS of human subjects between LC-MS/MS and RF-MS/MS is significant (n=187, p<0.0001).
B. ΔDiHS-0S concentration. Correlation in blood (plasma or serum) ΔDiHS-0S of human subjects between LC-MS/MS and RF-MS/MS is significant (n=187, p<0.0001).
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Figure 10: Chromatograms of disaccharides from the rat model with MPS VI (urine). ΔDi-4S comprises DS, and KS comprises KS1 and KS2.
Citation: Tomatsu S, Shimada T, Mason RW, Kelly J, LaMarr WA, et al. (2014) Assay for Glycosaminoglycans by Tandem Mass Spectrometry and its 
Applications. J Anal Bioanal Tech S2: 006. doi:10.4172/2155-9872.S2-006
Page 12 of 13
Special Issue 2 • 2014J Anal Bioanal TechISSN:2155-9872 JABT, an open access journal 
[40]. KS chains of fibromodulin in articular cartilage are highly sulfated 
compared to that in cornea [41,42], and the levels of sulfation in cornea 
and cartilage increase during normal aging [43,44]. The mechanism of 
alteration of their sulfation levels remains unknown. However, corneas 
in patients with macular corneal dystrophy (MCD) have been reported 
to synthesize low-sulfated KS, resulting in corneal clouding, and 
sulfate groups attached to KS play critical roles in maintaining corneal 
transparency [45]. Investigation of sulfation level in each disease and 
physiological status should help elucidate the mechanism of roles of 
GAGs. 
Thus, GAGs assayed by tandem mass spectrometry can be used 
as biomarkers not only for diagnosis, prognosis, and monitoring 
therapeutic effects for MPS but may also prove valuable for study of 
other diseases such as OA, DM, and spinal cord injury and physiological 
roles. The analysis technique should also be applicable to other species.
The mechanism of alteration of GAGs levels and their sulfation 
levels remains unknown. Investigation of each GAG level and its 
sulfation level in each disease and physiological status should help 
elucidate the mechanism of secondary alteration of GAGs and their 
roles. 
Conclusion
In conclusion, both LC-MS/MS and RF-MS/MS methods provide a 
comparable sensitivity and accuracy for simultaneous measurement of 
three GAGs (DS, HS, and KS).Advantage of use of LC-MS/MS is that 
ΔDi-6S (C6S), ΔDi-4S (DS), and DiHS-6S with the same molecular 
weight can be separated leading to accuracy and specificity of the 
differential diagnosis although it takes 3 min per sample to be analyzed. 
The RapidFire platform should provide both high throughput and 
economic advantages as a screening system for MPS, when compared 
with the conventional LC-MS/MS methodologies and has the potential 
of being applied to screening for other inherited metabolic disorders, 
although this system cannot recognize molecules with the same 
molecular weight separately.
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